IBRX

NASDAQ HEALTHCARE

Immunitybio Inc

$8.44

-$0.20 (-2.31%)

Live quote

52w: $1.95 – $12.43

Loading chart…

P/E Ratio—

P/B Ratio—

EV/EBITDA—

Debt/Equity—

ROE—

ROIC—

Revenue Growth668.31%

Gross Margin—

ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy.

Own IBRX? Track it here.

Create a free account to add IBRX to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account